We are live on
!
Find out more
TGI
TRV GP IV Portfolio holdings
AUM
$267M
1-Year Est. Return
965.83%
This Fund
S&P 500
This Quarter
Est. Return
+44.93%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$18.8M
(-6.9%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-41.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAZE
Maze Therapeutics
MAZE
|
+$55M |
| 2 |
Tango Therapeutics
TNGX
|
+$51.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OPL
WAM
IP
SIA
CFG
EU
PC
ALC
TRV GP IV's Q4 2025 Portfolio in Review
As of Q4 2025, TRV GP IV held 2 positions worth $255M, down 6.9% from $274M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP IV withdrew a net $107M in Q4 2025, reducing 2 holdings. Its largest reduction was Maze Therapeutics, cutting an estimated $55M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP IV's biggest Q4 2025 reduction was Maze Therapeutics, cutting an estimated $55M.
- TRV GP IV's ten largest holdings make up 100% of its $255M portfolio in Q4 2025.
- TRV GP IV opened 0 new positions and closed 0 in Q4 2025.
- TRV GP IV's portfolio value fell 6.9% quarter-over-quarter to $255M.
Based on TRV GP IV's 13F filing for Q4 2025, filed 13 Feb 2026.